Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Method for manufacturing thin film transistor and method for manufacturing display device
Light transformation particle and photobioreactor
Method and device for managing devices in device management system
Compositions and methods for concentrating and depleting microorganisms
Methods, systems, and products for searching interactive menu prompting systems
Switched capacitor amplifier
Method and system for placing an emergency call
  Randomly Featured Patents
Core for a sound absorbing panel
Process for cooling melamine synthesis waste gases
Method for fabricating thin-film image sensing devices
Disposable diaper having skin-contacting topsheet provided with elastic opening and method for making the elastic opening
Pyrazine aldimine compounds as antimicrobial agents
Carriage translating mechanism for video disc player
Release sheet for use with multicomponent reactive urethane systems and method of manufacture
Hydrazine derivatives
Transmission apparatus, transmission method, communication apparatus, and program
System, method and computer program product for an authentication management infrastructure